Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ISC 17536

Next Previous
X
Search
Drug Profile

ISC 17536

Alternative Names: GRC 17536 potassium powder for inhalation - Glenmark Pharmaceuticals; GRC-17536; ISC-17536

Latest Information Update: 21 Dec 2020

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Glenmark Pharmaceuticals Ltd
  • Class Analgesics; Anti-inflammatories; Antiasthmatics; Antitussives
  • Mechanism of Action TRPA1 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Cough; Neuropathic pain
  • Phase I/II Allergic asthma

Most Recent Events

  • 02 Oct 2020 Glenmark Pharmaceuticals plans a phase I trial in healthy volunteers in India (CTRI2020-09-028094),
  • 15 Oct 2019 Ichnos Sciences is a spin off from Glenmark Holdings SA
  • 18 Sep 2017 GRC 17536 is still in clinical trials for Neuropathic pain and Respiratory disorders (Glenmark pipeline, September 2017)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top